Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Flutamide rarely causes liver toxicity in prostate cancer patients.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

AHR ligands could treat inflammatory skin diseases.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.